third party risk management software

Search results

- LiveOne (Nasdaq: LVO) Reports Record Fiscal Year 2024 Financial Results
  NewMediaWire via Yahoo Finance· 2 days ago
  Record Revenue of $118.4M, an Increase of 19% from Prior Year Record Adjusted EBITDA* (excluding CPS...
- GM Envolve Connects Fleet Managers with Latest Fleet Vehicles and Tools
  Automotive Fleet· 4 days ago
  One engaging way an automotive manufacturer can spur interest in its vehicles is to host a...
- Forbes Daily: Nvidia Within Striking Distance Of Surpassing Apple
  Forbes· 3 days ago
  The concept of the luxury traveler, which a new McKinsey report defines as someone who spends at...
- Small Business - Picayune Item | Picayune Item
  The Picayune Item· 2 days ago
  Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next generation MAGE-A4 TCR T-cell therapy) produced on Galapagos’ decentralized manufacturing platform in patients with head